Your browser doesn't support javascript.
loading
Multi-omics analyses reveal novel effects of PLCγ2 deficiency in the mouse brain.
Hopp, Sarah C; Rogers, Juliet Garcia; Smith, Sabrina; Campos, Gabriela; Miller, Henry; Barannikov, Savannah; Kuri, Eduardo Gutierrez; Wang, Hu; Han, Xianlin; Bieniek, Kevin F; Weintraub, Susan T; Palavicini, Juan Pablo.
Affiliation
  • Hopp SC; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio.
  • Rogers JG; Department of Pharmacology, University of Texas Health Science Center San Antonio.
  • Smith S; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio.
  • Campos G; Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center San Antonio.
  • Miller H; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center San Antonio.
  • Barannikov S; Department of Pharmacology, University of Texas Health Science Center San Antonio.
  • Kuri EG; Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center San Antonio.
  • Wang H; Costa Rica Institute of Technology (TEC).
  • Han X; Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center San Antonio.
  • Bieniek KF; Department of Pathology and Laboratory Science, University of Texas Health Science Center San Antonio.
  • Weintraub ST; Department of Pharmacology, University of Texas Health Science Center San Antonio.
  • Palavicini JP; Sam and Ann Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center San Antonio.
bioRxiv ; 2023 Dec 08.
Article in En | MEDLINE | ID: mdl-38106102
ABSTRACT
Phospholipase C gamma-2 (PLCγ2) catalyzes the hydrolysis of the membrane phosphatidylinositol-4,5-bisphosphate (PIP2) to form diacylglycerol (DAG) and inositol trisphosphate (IP3), which subsequently feed into numerous downstream signaling pathways. PLCG2 polymorphisms are associated with both reduced and increased risk of Alzheimer's disease (AD) and with longevity. In the brain, PLCG2 is highly expressed in microglia, where it is proposed to regulate phagocytosis, secretion of cytokines/chemokines, cell survival and proliferation. We analyzed the brains of three-month-old PLCγ2 knockout (KO), heterozygous (HET), and wild-type (WT) mice using multiomics approaches, including shotgun lipidomics, proteomics, and gene expression profiling, and immunofluorescence. Lipidomic analyses revealed sex-specific losses of total cerebrum PIP2 and decreasing trends of DAG content in KOs. In addition, PLCγ2 depletion led to significant losses of myelin-specific lipids and decreasing trends of myelin-enriched lipids. Consistent with our lipidomics results, RNA profiling revealed sex-specific changes in the expression levels of several myelin-related genes. Further, consistent with the available literature, gene expression profiling revealed subtle changes on microglia phenotype in mature adult KOs under baseline conditions, suggestive of reduced microglia reactivity. Immunohistochemistry confirmed subtle differences in density of microglia and oligodendrocytes in KOs. Exploratory proteomic pathway analyses revealed changes in KO and HET females compared to WTs, with over-abundant proteins pointing to mTOR signaling, and under-abundant proteins to oligodendrocytes. Overall, our data indicate that loss of PLCγ2 has subtle effects on brain homeostasis that may underlie enhanced vulnerability to AD pathology and aging via novel mechanisms in addition to regulation of microglia function.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article Country of publication: United States